Pacira Biosciences Inc. held its Annual Meeting of Stockholders on June 10, 2025, in Parsippany, New Jersey, and online. Stockholders approved the Amended and Restated 2011 Stock Incentive Plan, increasing the number of shares of common stock authorized for grant by 2,500,000. The election of three Class II directors was also approved. The appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. An advisory vote to approve the compensation of named executive officers was not approved. An advisory vote determined the frequency of future advisory votes on executive compensation.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.